Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NOW vs MRNA✓SelectedUSD · MRNANOW vs MRNA performance historyLatest closeAs of-1.42%11/20
Stock and ETF performance explorer

NOW vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-33.3%
MRNA return
-27.3%
Excess return
-6.0%
Maximum drawdown
-64.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.4%-2.2%+0.8%-1.2%
7D-14.3%-12.7%-1.6%-13.4%
30D-42.8%-20.7%-22.1%-41.9%
3M-32.5%+46.3%-78.7%-35.2%
6M-15.2%+305.2%-320.4%-32.7%
YTD-42.8%+561.2%-604.1%-59.4%
1Y-45.3%+772.1%-817.4%-63.3%
3Y-34.3%+147.0%-181.3%-49.0%
All-33.3%-27.3%-6.0%-35.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling